1 research outputs found
âZipped Synthesisâ by Cross-Metathesis Provides a Cystathionine βâSynthase Inhibitor that Attenuates Cellular H<sub>2</sub>S Levels and Reduces Neuronal Infarction in a Rat Ischemic Stroke Model
The
gaseous neuromodulator H<sub>2</sub>S is associated with neuronal
cell death pursuant to cerebral ischemia. As cystathionine β-synthase
(CBS) is the primary mediator of H<sub>2</sub>S biogenesis in the
brain, it has emerged as a potential target for the treatment of stroke.
Herein, a âzippedâ approach by alkene cross-metathesis
into CBS inhibitor candidate synthesis is demonstrated. The inhibitors
are modeled after the pseudo-<i>C</i><sub>2</sub>-symmetric
CBS product (l,l)-cystathionine. The âzippedâ
concept means only half of the inhibitor needs be constructed; the
two halves are then fused by olefin cross-metathesis. Inhibitor design
is also mechanism-based, exploiting the favorable kinetics associated
with hydrazine-imine interchange as opposed to the usual imineâimine
interchange. It is demonstrated that the most potent âzippedâ
inhibitor <b>6S</b> reduces H<sub>2</sub>S production in SH-SY5Y
cells overexpressing CBS, thereby reducing cell death. Most importantly,
CBS inhibitor <b>6S</b> dramatically reduces infarct volume
(1 h post-stroke treatment; âź70% reduction) in a rat transient
middle cerebral artery occlusion model for ischemia